Antares Pharma IncAntares Pharma Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

This webpage contains a free ESG assessment covering Antares Pharma Inc. The Disclosure rating includes seventeen UN SDGs including: 'Good Health & Wellbeing', 'Climate Action' and 'Life below Water'. Jump to the end of the webpage for potential risks for Antares Pharma Inc based on sector, geography and size.

Antares Pharma Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.9; made up of an environmental score of 0.0, social score of 4.6 and governance score of 4.0.

SDG Transparency Score for Antares Pharma Inc 

2.9

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Antares Pharma Inc 
0.0

Environmental

4.6

Social

4.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
.........
1800Wuhan Hiteck Biological Pharma Co Ltd
3.0
Medium
1800Zhejiang Jingxin Pharmaceutical Co Ltd
3.0
Medium
1836Antares Pharma Inc
2.9
Medium
1836Aarey Drugs and Pharmaceuticals Ltd
2.9
Medium
1836Alpha Teknova Inc
2.9
Medium
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Antares Pharma Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Antares Pharma Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Antares Pharma Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Antares Pharma Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Antares Pharma Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Antares Pharma Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Antares Pharma Inc offer flexible work?

LockedSign up for free to unlock

Does Antares Pharma Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Antares Pharma Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Antares Pharma Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Antares Pharma Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Antares Pharma Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Antares Pharma Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Antares Pharma Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Antares Pharma Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Antares Pharma Inc disclose water use targets?

LockedSign up for free to unlock

Does Antares Pharma Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Antares Pharma Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Antares Pharma Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Antares Pharma Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Antares Pharma Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Antares Pharma Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Antares Pharma Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Antares Pharma Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Antares Pharma Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Antares Pharma Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Antares Pharma Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Antares Pharma Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Antares Pharma Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Antares Pharma Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Antares Pharma Inc disclose its waste policy?

LockedSign up for free to unlock

Does Antares Pharma Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Antares Pharma Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Antares Pharma Inc disclose energy use targets?

LockedSign up for free to unlock

Does Antares Pharma Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Antares Pharma Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Antares Pharma Inc
These potential risks are based on the size, segment and geographies of the company.

Antares Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of pharmaceutical products and technologies that address unmet needs in targeted therapeutic areas. It develops, manufactures, and commercialize novel therapeutic products using its drug delivery systems. The company's injection products include XYOSTED for subcutaneous administration of testosterone replacement therapy in adult males; OTREXUP OTREXUP a subcutaneous methotrexate injection indicated for adults with severe active rheumatoid arthritis, children with active polyarticular juvenile idiopathic arthritis, and adults with severe recalcitrant psoriasis; and NOCDURNA sublingual tablets indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least two times per night to urinate. Its injection products also comprise generic Epinephrine Injection USP products indicated for emergency treatment of severe allergic reactions, including anaphylaxis in adults and certain pediatric patients; Sumatriptan Injection USP indicated for the acute treatment of migraine headaches and cluster headache in adults; and Makena subcutaneous auto injector drug-device combination product indicated to reduce the risk of preterm birth in women, as well as Teriparatide injection used for the treatment of osteoporosis in postmenopausal women and men at increased risk of fracture, and for glucocorticoid induced osteoporosis in men and women. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; QuickShot auto injectors; and drug/device product for urologic oncology and endocrinology. The company have strategic alliances and partnership arrangements pharmaceutical companies, including Pfizer, Idorsia, Teva, and AMAG. Antares Pharma, Inc. was founded in 1978 and is headquartered in Ewing, New Jersey.

Sorry!

Failed to process!